FDA approves Omega Laboratories for manufacturing 10-Sep-2019 By Vassia Barba Sagent announces the approval of its subsidiary’s facility in Canada to manufacture small molecule drug products for the US market.
NEWS IN BRIEF Sagent acquires US facility with an eye on future biosimilar products 12-Mar-2019 By Staff reporter Sagent purchases Xellia’s FDA-approved site in North Carolina, which has capabilities to manufacture both small molecule and biologic products.